Stockholm III trial
The Stockholm III trial is a randomised, multicentre trial, comparing different radiationtherapy courses in primary resectable rectal cancer.
Patients are randomised between one of the following arms:
- Preoperative radiotherapy 5 x 5 Gy with surgery within one week
- Preoperative radiotherapy 5 x 5 Gy with surgery after 4-8 weeks
- Preoperative radiotherapy 25 x 2 Gy with surgery after 4-8 weeks
Primary resectable, biopsy proven adenocarcinoma of the rectum, without signs of distant metastases where abominal surgery is planned.